×

Medigus to Hold Company Update Event at DDW(R) 2015

OMER, Israel, May 15, 2015 (GLOBE NEWSWIRE) -- Medigus Ltd. (MDGS.TA), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced today that the company will hold a company update event at DDW® 2015 (Digestive Disease Week) on Monday, May 18 from 7:30 – 8:45 a.m. EDT. DDW 2015 will be held May 16-19, 2015 in Washington, D.C. at the Walter E. Washington Convention Center.

Event Speakers Include:

  • Chris Rowland – CEO, Medigus
  • Prof. Stavros Stavropoulos, MD – Chief of Endoscopy; Director, Program in Advanced GI Endoscopy (PAGE); Adjunct Professor of Clinical Medicine, Columbia University, College of Physicians and Surgeons; New York, NY
  • Prof. Dr. Ralf Kiesslich – Director of the Center for Internal Medicine; Head of Interdisciplinary Endoscopic Unit, Horst-Schmidt-Kliniken; Wiesbaden, Germany
  • Dr. Ali Lankarani – Advanced Theraputic Endoscopy Center (ATEC) at the Borland-Groover Clinic, St. Vincent's HealthCare; Jacksonville, FL

The event will be recorded and, following its conclusion, may be accessed at http://www.medigus.com/investor-relations.

About DDW®

Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 3-6, 2014, at McCormick Place, Chicago. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org.

About Medigus

Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions. Medigus is a pioneer developer of a unique proprietary endoscopic device, the MUSE(TM) system, to treat gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world. As an expert in micro-endoscopic devices, Medigus has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCam(TM) 1.2, which to the best of the company's knowledge, is the smallest in the world. These innovative cameras are suitable for both medical and industrial applications. The MUSE system incorporates Medigus' revolutionary micro ScoutCam technology. Based on its proprietary technologies, Medigus designs and manufactures endoscopy and micro camera systems for partner companies, including major players in the medical and industrial fields. The company is committed to providing integrated solutions to meet all of its customer's imaging needs. Medigus is traded on the TASE (Tel-Aviv Stock Exchange). To learn more about the company's advanced technology, please visit www.medigus.com or www.microscoutcam.com.

CONTACT: INVESTOR RELATIONS CONTACT: Miri Segal-Scharia Hayden/MS-IR LLC 917-607-8654 msegal@ms-ir.com MEDIA CONTACT: Chantal Beaudry/ Carrie Yamond Lazar Partners Ltd. 212-867-1762 cbeaudry@lazarpartners.com cyamond@lazarpartners.com

Source:Medigus Ltd.